You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 17, 2025

Drug Price Trends for TEMAZEPAM


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for TEMAZEPAM

Best Wholesale Price for TEMAZEPAM

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
TEMAZEPAM 7.5MG CAP Amerisource Health Services LLC dba American Health Packaging 68084-0549-21 3X10 55.01 2023-09-15 - 2028-09-14 Big4
TEMAZEPAM 7.5MG CAP Amerisource Health Services LLC dba American Health Packaging 68084-0549-21 3X10 70.50 2023-09-15 - 2028-09-14 FSS
TEMAZEPAM 7.5MG CAP Amerisource Health Services LLC dba American Health Packaging 68084-0549-21 3X10 54.18 2024-01-01 - 2028-09-14 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Temazepam

Introduction to Temazepam

Temazepam, a member of the benzodiazepine class, is widely used for the short-term treatment of insomnia. It is known for its calming effects and is available in various strengths, including 7.5mg, 15mg, 22.5mg, and 30mg capsules.

Global Benzodiazepine Market Context

The global benzodiazepine drugs market, which includes temazepam, is significant and growing. As of 2022, this market was valued at US$ 2.35 billion and is projected to reach US$ 3.1 billion by 2032, growing at a CAGR of 2.8%[3][4].

Market Size and Growth of Temazepam

Within the benzodiazepine market, temazepam holds a notable share. The 7.5mg segment of temazepam, for instance, accounted for a significant share of the global temazepam market in 2023 and is expected to experience substantial growth in the near future[1].

Regional Analysis

The market for temazepam is segmented across major regions including North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is expected to remain a favorable regional market due to the high prevalence of mental disorders and the resultant demand for anxiolytics and hypnotics[3].

Application and End-Use Segments

Temazepam is primarily used in hospitals and clinics for the treatment of insomnia and other sleep disorders. The hospital segment is anticipated to expand at a significant CAGR, retaining its position throughout the forecast period[1].

Price Projections and Cost Analysis

The prices of temazepam capsules vary based on the dosage and quantity. Here are some current price ranges:

  • 7.5mg: Prices range from $67.89 to $105.37 for 30 capsules[2].
  • 15mg: Prices range from $11.87 to $128.20 for varying quantities, with the lowest price per unit being around $0.13 for 500 capsules[2].
  • 22.5mg: Prices start from $105.32 for 30 capsules[2].
  • 30mg: Prices range from $14.05 to $161.30 for varying quantities, with the lowest price per unit being around $0.15 for 500 capsules[2].

Using discount programs or coupons can significantly reduce the cost. For example, a 30mg capsule of temazepam can cost as little as $2.56 with a SingleCare prescription savings card, compared to the retail price of $38.72[5].

Market Drivers and Opportunities

Several factors drive the growth of the temazepam market:

  • Increasing Prevalence of Mental Disorders: Rising cases of anxiety and insomnia globally contribute to higher demand for benzodiazepines like temazepam[3][4].
  • Growing Mental Health Awareness: Increased acceptance of pharmacological interventions for mental health conditions boosts market growth[4].
  • Aging Population: Older adults are more susceptible to anxiety and sleep disorders, leading to higher prescription rates[4].
  • Research and Development: Ongoing efforts to develop novel formulations and indications for benzodiazepines are expected to drive market growth[4].

Challenges and Restraints

Despite the growth opportunities, the temazepam market faces several challenges:

  • Regulatory Scrutiny: Benzodiazepines, including temazepam, are subject to strict regulations due to their potential for abuse and dependency.
  • Side Effects and Safety Concerns: The risk of side effects and long-term use complications can impact market growth[3].

Competitive Landscape

The temazepam market is competitive, with key players such as Ascend Laboratories, Mylan, and others focusing on strategy building and product portfolio expansion to strengthen their market position[1].

Future Outlook

The future of the temazepam market looks promising, driven by the increasing need for effective treatments for mental health disorders. Here are some key projections:

  • Short Term (2024 to 2025): Rising use of benzodiazepine drugs for mental disorders will favorably affect market growth[3].
  • Medium Term (2025 to 2028): Product development with minimal side effects will lead to higher acceptance of benzodiazepine drugs[3].
  • Long Term (2028 to 2032): Rising urbanization and extraordinary work pressure will drive market growth over the long term[3].

Key Takeaways

  • The global temazepam market is part of the larger benzodiazepine market, which is expected to grow significantly.
  • North America is a key region for temazepam sales due to high prevalence of mental disorders.
  • Prices of temazepam vary widely based on dosage and quantity, with discounts available through various programs.
  • Market growth is driven by increasing mental health awareness and the aging population.
  • Regulatory scrutiny and side effects are significant challenges.

Frequently Asked Questions (FAQs)

Q: What is the primary use of temazepam? A: Temazepam is primarily used for the short-term treatment of insomnia.

Q: How is the global benzodiazepine market projected to grow? A: The global benzodiazepine market is expected to grow at a CAGR of 2.8% from 2022 to 2032, reaching a market size of US$ 3.1 billion by 2032[3].

Q: Which region is expected to be the most favorable for temazepam sales? A: North America is expected to be the most favorable regional market for temazepam due to the high prevalence of mental disorders[3].

Q: How can the cost of temazepam be reduced? A: The cost of temazepam can be significantly reduced using discount programs or coupons, such as those offered by SingleCare[5].

Q: What are the main drivers of the temazepam market? A: The main drivers include the increasing prevalence of mental disorders, growing mental health awareness, and the aging population[3][4].

Cited Sources

  1. Global Temazepam Capule Market Report 2024 Edition - Cognitivemarketresearch.com
  2. Temazepam Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
  3. Benzodiazepine Drugs Market Size, Share & Growth Trajectory 2032 - Fact.MR
  4. Benzodiazepine Drugs Market Size & Share | Growth Forecasts 2032 - Gminsights.com
  5. Temazepam Coupons & Prices - SingleCare.com

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.